All News
The Influence of Obesity on Choice of Biologic Agent in Rheumatoid Arthritis
In rheumatoid arthritis we have a wide range of options available to us when we progress to a biologic treatment option. We have little to differentiate between these agents based on the clinical trials.
Read ArticleMike Putman EBRheum ( View Tweet)
Links:
Bella Mehta bella_mehta ( View Tweet)
Links:
Dr. John Cush RheumNow ( View Tweet)
Large GWAS Study Reveals Genetic Basis for Osteoarthritis Phenotypes
Cell has published the results of a multinational, GWAS meta-analyses of 826,690 individuals that included 177,517 osteoarthritis patients, finding 52 previously unknown osteoarthritis (OA) genetic risk variants and linking OA genetic risks with joint distribution and pain
Read ArticleNew Hope for NonAlcoholic Fatty Liver Disease
The current issue of the NEJM has two articles on nonalcoholic fatty liver disease (NAFLD also called NASH - nonalcoholic steatohepatitis), one dealing with the prognoses, outcomes and mortality of NAFLD and another prospective and promising interventional trial in NASH patients.
Read ArticleLinks:
Obesity Rates Rise During the Pandemic
New data from the Centers for Disease Control and Prevention shows that obesity rates have risen in the USA during the pandemic. Sixteen states have obesity rates of 35% or higher - that's four more than last year, adding Delaware, Iowa, Ohio and Texas to the list.
Read ArticleRheumNow Podcast – Jack of All Subspecialties (10.1.2021)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Read ArticleRheumNow Podcast – Do More DMARDs Mean More Switching? (9.17.2021)
Smartphones and diet; COVID-19 and the numbers - reassuring or not, and what about masks?; and do more drugs mean more switching, less persistence, and patient adherence goes up...or down? All this and more news and journal reports in this week's episode.
Read ArticleLinks:
Dr. John Cush RheumNow ( View Tweet)